Pricing of orphan drugs in oncology and rare diseases
Objective: The objective of this paper is to determine an upper price limit for an orphan drug by taken a broader perspective and, including also other monetary and non-monetary values for the society. Methods: This model is based on the expected free cash flows and the required minimum rate of retu...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2020-01-01
|
| Saila: | Journal of Market Access & Health Policy |
| Gaiak: | |
| Sarrera elektronikoa: | http://dx.doi.org/10.1080/20016689.2020.1838191 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|